BGS expanding during pandemic

BGS Beta-Gamma-Service GmbH & Co. KG continues its expansion: In particular, the pandemic-related rise in demand for sterilization capacities for biotechnological products and pharmaceutical primary packaging material ensured sound revenue increases. Only last year in 2020 did BGS invest eleven million euros in the expansion of its facilities and locations. This year sees further investments in the mid-seven-digit range.

Author: Lena Prinz

Published: Last updated:

News, Corporate

1 Min. Reading time
Test tubes Sample collection with green lids
Test tubes Sample collection with green lids

Health protection through sterile products: With the sterilization, for example, of medical disposables such as catheters or laboratory consumables, BGS provides a systemically relevant service not only in the pandemic.

“Sterilization with rays is generally an indispensable method of producing sterile products for health care. In the past year, we were also able to record a significant surge in demand for biotechnology products, consumables for laboratories and primary packaging materials for the pharmaceutical industry,” explains Managing Director of BGS, Dr. Andreas Ostrowicki.

In addition, the stable development in the construction industry resulted in a slight increase of sales in the other business division, namely radiation crosslinking of plastics: “With the help of radiation crosslinking of tube and rod products to name a couple of examples, we ensure the usage properties of systems implemented in new buildings or renovation projects,” declares Ostrowicki. The high degree of material stability of crosslinked plastics is especially relevant for lightweight construction in the field of electromobility. BGS expects an increasing demand this year for radiation crosslinked components in the automotive industry.

Investments in expansion of capacities

In order to cater to the increased demand especially in the area of sterilization, BGS invested in the expansion of its capacities last year. “Our goal is to ensure long-term supply for our customers in the future. With this in mind, we have invested approximately eleven million euros in the expansion of our facilities and locations,” explains Managing Director Ostrowicki.

More News

  • bgs als regional sponsor IMRP 2027

    Published on 21.10.2025News, Corporate

    IMRP 2027 Germany: BGS is a regional sponsor!

    From April 12 to 16, 2027, the IMRP (International Meeting on Radiation Processing) will take place at the Crowne Plaza Düsseldorf-Neuss. As a regional sponsor, BGS is looking forward to actively supporting the event and promoting exchange within the global…

  • Frankfurt im Hintergrund und darüber der Text CPHI

    Published on 09.09.2025News, Radiation sterilization

    BGS at CPHI Frankfurt 2025

    Visit BGS Beta-Gamma-Service from October 28 to 30, 2025, at CPHI Worldwide in Frankfurt am Main - the leading international trade fair for the pharmaceutical industry. You will find us at booth 4.1J24 in the Contract Manufacturing hall.